Jeff Machat, MD, FRCSC, DABO
Show Description +
Jeff Machat, MD, says he is excited by inlay technology and has been successfully incorporating it into his practice. He notes his experience with the two commercially available products (Kamra; Acufocus and the Raindrop; ReVision Optics). The inlays exhibit a high safety profile, he says, and have the unique and important aspect of removability. The removal rate is only 2% to 4%, revealing how much the procedure has evolved over time, increasing the safety and efficacy of corneal inlays.
Posted: 1/25/2017
Jeff Machat, MD, FRCSC, DABO
Jeff Machat, MD, says he is excited by inlay technology and has been successfully incorporating it into his practice. He notes his experience with the two commercially available products (Kamra; Acufocus and the Raindrop; ReVision Optics). The inlays exhibit a high safety profile, he says, and have the unique and important aspect of removability. The removal rate is only 2% to 4%, revealing how much the procedure has evolved over time, increasing the safety and efficacy of corneal inlays.
Posted: 1/25/2017
Please log in to leave a comment.